EFA Krill

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Vaccinium macrocarpon, Quantity: 65 mg; Evening Primrose Oil, Quantity: 20 mg (Equivalent: gamma-linolenic acid, Qty 2 mg); Salvia hispanica, Quantity: 100 mg; Linum usitatissimum, Quantity: 20 mg; euphausia superba oil, Quantity: 335 mg (Equivalent: eicosapentaenoic acid, Qty 40.2 mg; Equivalent: docosahexaenoic acid, Qty 18.43 mg); alpha lipoic acid, Quantity: 20 mg

Available from:

Modere Australia Pty Ltd

INN (International Name):

alpha lipoic acid,euphausia superba oil,Evening Primrose Oil,Linum usitatissimum,Salvia hispanica,Vaccinium macrocarpon

Pharmaceutical form:

Capsule, soft

Composition:

Excipient Ingredients: citric acid; sorbitol solution (70 per cent) (non-crystallising); purified water; Gelatin; vanillin; glycerol; iron oxide black; iron oxide red

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2014-03-27